Skip to main content
OpenTrials
Completed

NCT Number: NCT07355933

Metabolic Flexibility and Metabolic Heath in Human Obesity

This interventional study explores the relationship between improvements in metabolic health following weight loss and changes in whole-body fat mass and its distribution. The study focuses on adult men and women with excess body weight undergoing dietary energy restriction over 12 weeks. The primary research question is: Does a greater reduction in fat mass for a given weight loss correlate with more significant improvements in metabolic health?

Completed

Looking for future studies?

Notify Me

Key information

Age range

30 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Avda. Libertador Bernardo O´Higgins 340. Santiago. Chile.

Santiago, Chile

About this study

Obesity is a well-established risk factor for disruptions in metabolic health, which often precede cardiovascular disease and type-2 diabetes. While the precise pathophysiological mechanisms linking obesity to these conditions remain unclear, it is widely acknowledged that an increase in fat mass plays a central role, including the expansion of adipose tissue and the accumulation of lipids in non-adipose tissues. As a result, a primary approach to improving metabolic health is to reduce fat mass through negative energy balance. However, lifestyle changes or pharmacological interventions aimed at inducing a negative energy balance do not exclusively target fat mass and often result in the loss of fat-free mass to varying degrees. Given that higher fat mass, rather than fat-free mass, is more strongly associated with impaired metabolic health, strategies that maximize fat mass loss while preserving fat-free mass may offer more significant benefits for metabolic health. Surprisingly, there is a lack of evidence to support this hypothesis. To address this gap, it will be evaluated the relationship between changes in metabolic health and body composition, independent of overall weight loss, in individuals with overweight or obesity undergoing dietary energy restriction. It is hypothesized that greater fat mass reduction will be linked to more substantial improvements in metabolic health for a given weight loss.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • males or females
  • 30-55 y old
  • physically inactive (<600 MET´min/wk of self-reported moderate-vigorous physical activity
  • stable body weight for at least the past 6 months (±2 kg)
  • healthy according to medical history and routine hematology and biochemistry.

Exclusion criteria

  • Individuals with physiological (pregnancy, lactation) or pathological (under drug therapy for and/or having cardiovascular, liver, kidney, thyroid diseases)
  • conditions affecting energy metabolism or eating behavior
  • Subjects having low-fat (<20% energy) or low-carbohydrate (<45% energy) diets
  • Smokers and alcohol abusers

Treatment and study plan

Body Weight Loss

Other

Individuals will be prescribed a hypocaloric diet (1300 kcal/d). Individuals will receive a booklet detailing the type of meals and foods to be consumed in each mealtime. A dietitian will explain how to enhance dietary compliance. Every two weeks, body weight, vital signs, and adverse events will be monitored. In addition, food recalls will be conducted in order to optimize dietary energy restriction compliance. During weight maintenance, energy intake will be adjusted to energy requirements to maintain weight stability (±2.5 kg) for at least 3 weeks. During weight loss and maintenance, participants will be instructed to maintain their customary physical activity.

Primary outcomes

  1. Fasting serum triglyceride concentration

    Time frame: From enrollment to the end of weight maintenance period at 15-20 weeks

    In overnight fasted individuals, a blood sample will be drawn. Serum will be isolated and stored at -80C until assessment.

Secondary outcomes

  1. HOMA-IR

    Time frame: From enrollment to the end of weight maintenance period at 15-20 weeks.

    In overnight fasted individuals, a blood sample will be drawn for glucose and insulin assessment. HOMA-IR will be calculated using this formula: (glucose, mM * insulin, uU/mL)/22.5. Serum/Plasma will be isolated and stored at -80C until assessment.

Sponsors and collaborators

Lead sponsor

Jose Galgani

Other

Collaborators

  • Agencia Nacional de Investigación y Desarrollo

Registry information

Official study title

Metabolic Flexibility, Eating Behavior and Adipose Tissue Expandability: Role of This Triad in the Propensity to Human Obesity

Acronym: PROB

Important dates

Study start
2022
Primary completion
2025
Study completion
2025
First posted
Jan 21, 2026
Registry last updated
Feb 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.